摘要
目的观察黄芪注射液配合西药常规治疗慢性充血性心力衰竭的疗效及安全性。方法 110例患者随机分成对照组和治疗组,对照组54例给予西医常规抗心力衰竭治疗,治疗组56例在常规抗心力衰竭的基础上加用黄芪注射液40 ml,1次/d,两组均连续用药2周。结果临床疗效总有效率治疗组为91.07%,对照组为72.22%;心电图改善总有效率治疗组为87.50%,对照组为62.96%。两组在临床疗效和心电图改善方面均有显著差异(P<0.05),治疗组明显优于对照组。结论黄芪注射液配合西医常规抗心力衰竭治疗慢性充血性心力衰竭,比单纯西医常规治疗效果好,是非常有前景的治疗心力衰竭药物。
Objective To observe the clinical effect and safety of Astragalus Injection combine with routine treatment in treating chronic congestive heart failure （CHF）. Methods 110 patients of CHF were randomly divided into two groups. 56patients of the treatment group and 54 patients of the control group were all received routine medicine, at the same time, the treatment group was administered Astragalus Injection 40ml/d. The therapeutic course was two weeks. Results The Total clinical effective rate in the treatment group and the control group was 91.07% and 72.22% respectively. The total effective rate of ECG in the treatment group was87. 50%and 71.43% in the control group; Both the treatment group and the control group had significant difference in the clinical efficiencies and electrocardiogram efficiencies （ P 〈 0.05 ） , The treatment group was significantly better than the control group. Conclusion Astragalus Injection combine with conventional anti - HF therapy for treating CHF has affirmatively curative effect, and also it is a very promising durg used intravenously in heart fail- life.
出处
《中国医学创新》
CAS
2011年第21期150-151,共2页
Medical Innovation of China
关键词
慢性充血性心力衰竭
黄芪
Chronic congestive heart failure
Astragalus
